Head-to-head · Value Score
CoreAge Rx vs Hims & Hers
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Hims & Hers a 80. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$149/mo
Save ~89% vs brand-nameHims & Hers
#21 · Grade B · Good Value
Est. first month
$199/mo
Save ~85% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 80 — an est. $149/mo first month, with no teaser step-up baked in. Hims & Hers isn't out of it: People who want a familiar consumer brand and a visible semaglutide price.
CoreAge Rx is also our overall #1 pick across the whole deals board — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Hims & Hers |
|---|---|---|
| Value Score | 93 (A+) | 80 (B) |
| Est. first month | $149/mo | $199/mo |
| Save vs brand-name | ~89% | ~85% |
| Semaglutide | $149/mo | $199/mo |
| Tirzepatide | $349/mo | Not disclosed |
| Both molecules | Yes | No |
| Pricing | Flat — no step-up | Flat — no step-up |
| Coverage | All 50 states | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Hims & Hers
A familiar, app-first brand with an up-front $199 semaglutide price and nationwide reach.
Why it's a deal
- Up-front $199 semaglutide
- Available in all 50 states
- Slick app experience and strong brand trust
The fine print
- Tirzepatide pricing not consistently disclosed
- Compounded supply has drawn industry-wide regulatory scrutiny
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.